Urgent.News

What's breaking now, across thousands of outlets.

Editions

Health & Medicine

FDA rejects Osteal combo therapy to treat joint-implant infections

The FDA late last month rejected Osteal Therapeutics' lead combo therapy that sought to more quickly fight the bacteria or other microorganisms that infect the area around a joint implant. The company has yet to ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Thursday 20 August →